Three years after Pulitzer Prize-winning writer and oncologist Dr. Siddhartha Mukherjee founded Vor Biopharma, the company finally has its first executive.
Robert Ang, formerly the chief business officer for Neon Therapeutics, will be Vor’s first chief executive officer, the company announced Wednesday.
Vor is one of several startups developing cell therapies for cancer, though specifics about the company’s plans had been sparse until recently. In May, the company’s scientific founders published a preclinical proof-of-concept paper in the Proceedings of the National Academy of Sciences that laid out just what they hope the company will do.
About the Author Reprints
